Clinical studies have documented that the activation of cannabis receptors as well as the production of the endogenous cannabinoid anandamide are essential for proper prenatal and postnatal development. Authors note that endocannabinoids are present in the uterus and in mother's milk, and that activation of the cannabinoid receptors in newborns is critical to the development of the oral-motor and nervous systems. Anandamide also has neuroprotectant properties in the developing postnatal brain, and affects "prefrontal cortical functions, memory and motor and addictive behaviors."

Authors concluded, "The medical implications of these novel developments are far reaching and suggest a promising future for cannabinoids in pediatric medicine" for a variety of conditions, including cystic fibrosis.

Study:  October 7, 2004, European Journal of Pharmacology